MindWalk Holdings Corp. reported record sales, improved margins, and a strengthened balance sheet post-divestiture. Learn more about HYFT stock here.

Published in Nature Communications, a new study uncovers critical protein biomarkers that predict functional decline in Duchenne Muscular Dystrophy (DMD), opening doors to more personalized care and ...

Microsoft transforms Windows 11 with AI-powered Copilot, adding voice control, vision tools, and autonomous agents to ...

Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...

The latest update is out from MindWalk Holdings ( (HYFT) ).

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...

Patent number 3,174,137, which is titled Gut Microbiota Bioactivated PDE4 Inhibitor Precursors, encompasses the composition ...

Early testing suggests that applying structured data extends your visibility and stability in an AI-generated snippet.

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical ...

Princeton Biopartners, a leading consultancy in Integrated Evidence Generation Planning and Medical Affairs strategy, today ...

UMass Amherst engineers have built an artificial neuron powered by bacterial protein nanowires that functions like a real one ...